Christopher Scott Frei

Title: Innovations of Christopher Scott Frei

Introduction

Christopher Scott Frei is an accomplished inventor based in Weymouth, MA (US). He has made significant contributions to the field of biotransformation and glycosylation through his innovative patents. With a total of 2 patents to his name, Frei's work focuses on the production of steviol glycosides, which are important for various applications in the food and pharmaceutical industries.

Latest Patents

Frei's latest patents include methods for the production of steviol glycosides through whole cell biotransformation of steviol glycoside intermediates. In various aspects and embodiments, these inventions provide microbial cells and methods for producing advanced glycosylation products from lower glycosylated intermediates. The microbial cells express one or more UDP-dependent glycosyl transferase enzymes in the cytoplasm, facilitating the glycosylation of the intermediates. When incubating the microbial strain with a plant extract or fraction comprising the intermediates, these glycosylated intermediates become available for further glycosylation by the cell. The advanced glycosylation products can then be recovered from the media and/or microbial cells.

Career Highlights

Christopher Scott Frei is currently associated with Manus Bio Inc., where he continues to advance his research and innovations. His work has positioned him as a key figure in the development of sustainable bioprocesses for glycosylation.

Collaborations

Frei collaborates with notable colleagues, including Ajikumar Parayil Kumaran and Christine Nicole S Santos, who contribute to his research endeavors and innovations.

Conclusion

Christopher Scott Frei's contributions to the field of biotransformation and glycosylation through his patents highlight his innovative spirit and dedication to advancing scientific knowledge. His work at Manus Bio Inc. continues to pave the way for new applications in various industries.